These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 37098945)

  • 1. Insight into the Antibacterial Action of Iodinated Imine, an Analogue of Rafoxanide: a Comprehensive Study of Its Antistaphylococcal Activity.
    Krátký M; Konečná K; Janďourek O; Diepoltová A; Vávrová P; Voxová B; Vejsová M; Bárta P; Bősze S
    Microbiol Spectr; 2023 Jun; 11(3):e0306422. PubMed ID: 37098945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacodynamics of telavancin studied in an in vitro pharmacokinetic model of infection.
    MacGowan AP; Noel AR; Tomaselli S; Elliott HC; Bowker KE
    Antimicrob Agents Chemother; 2011 Feb; 55(2):867-73. PubMed ID: 21078943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and In Vitro Activity of Polyhalogenated 2-phenylbenzimidazoles as a New Class of anti-MRSA and Anti-VRE Agents.
    Göker H; Karaaslan C; Püsküllü MO; Yildiz S; Duydu Y; Üstündağ A; Yalcin CÖ
    Chem Biol Drug Des; 2016 Jan; 87(1):57-68. PubMed ID: 26221778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of quinolinequinones with N-phenylpiperazine by conversion of hydroxyquinoline as a new class of antimicrobial agents targeting resistant pathogenic microorganisms.
    Yıldız M; Bayrak N; Yıldırım H; Çakmak SM; Yılmaz FN; Mataracı-Kara E; Shilkar D; Jayaprakash V; TuYuN AF
    Bioorg Chem; 2022 Nov; 128():106045. PubMed ID: 35921788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time-kill kinetics of oritavancin and comparator agents against Staphylococcus aureus, Enterococcus faecalis and Enterococcus faecium.
    McKay GA; Beaulieu S; Arhin FF; Belley A; Sarmiento I; Parr T; Moeck G
    J Antimicrob Chemother; 2009 Jun; 63(6):1191-9. PubMed ID: 19369269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cleistochlamys kirkii chemical constituents: Antibacterial activity and synergistic effects against resistant Staphylococcus aureus strains.
    Pereira F; Madureira AM; Sancha S; Mulhovo S; Luo X; Duarte A; Ferreira MJ
    J Ethnopharmacol; 2016 Feb; 178():180-7. PubMed ID: 26674158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repurposing Anthelmintics: Rafoxanide- and Copper-Functionalized SBA-15 Carriers against Methicillin-Resistant
    Ramírez-Hernández M; Norambuena J; Hu H; Thomas B; Tang C; Boyd JM; Asefa T
    ACS Appl Mater Interfaces; 2023 Apr; 15(14):17459-17469. PubMed ID: 36975176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repurposing of the Tamoxifen Metabolites to Treat Methicillin-Resistant Staphylococcus epidermidis and Vancomycin-Resistant Enterococcus faecalis Infections.
    Miró-Canturri A; Vila-Domínguez A; Caretero-Ledesma M; Ayerbe-Algaba R; Pachón J; Jiménez-Mejías ME; Smani Y
    Microbiol Spectr; 2021 Oct; 9(2):e0040321. PubMed ID: 34668743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and evaluation of new quinazolin-4(3H)-one derivatives as potent antibacterial agents against multidrug resistant Staphylococcus aureus and Mycobacterium tuberculosis.
    Gatadi S; Gour J; Shukla M; Kaul G; Dasgupta A; Madhavi YV; Chopra S; Nanduri S
    Eur J Med Chem; 2019 Aug; 175():287-308. PubMed ID: 31096152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacodynamic activity of ceftobiprole compared with vancomycin versus methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-intermediate Staphylococcus aureus (VISA) and vancomycin-resistant Staphylococcus aureus (VRSA) using an in vitro model.
    Zhanel GG; Voth D; Nichol K; Karlowsky JA; Noreddin AM; Hoban DJ
    J Antimicrob Chemother; 2009 Aug; 64(2):364-9. PubMed ID: 19454524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and synthesis of novel arylurea derivatives of aryloxy(1-phenylpropyl) alicyclic diamines with antimicrobial activity against multidrug-resistant Gram-positive bacteria.
    Canale V; Czekajewska J; Klesiewicz K; Papież M; Kuziak A; Witek K; Piska K; Niemiec D; Kasza P; Pękala E; Empel J; Tomczak M; Karczewska E; Zajdel P
    Eur J Med Chem; 2023 May; 251():115224. PubMed ID: 36958177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antistaphylococcal activity of DX-619, a new des-F(6)-quinolone, compared to those of other agents.
    Bogdanovich T; Esel D; Kelly LM; Bozdogan B; Credito K; Lin G; Smith K; Ednie LM; Hoellman DB; Appelbaum PC
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3325-33. PubMed ID: 16048943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maxamycins: Durable Antibiotics Derived by Rational Redesign of Vancomycin.
    Wu ZC; Boger DL
    Acc Chem Res; 2020 Nov; 53(11):2587-2599. PubMed ID: 33138354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of ZnO nanoparticles on methicillin, vancomycin, linezolid resistance and biofilm formation in Staphylococcus aureus isolates.
    Abdelraheem WM; Khairy RMM; Zaki AI; Zaki SH
    Ann Clin Microbiol Antimicrob; 2021 Aug; 20(1):54. PubMed ID: 34419054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rhamnolipid-Coated Iron Oxide Nanoparticles as a Novel Multitarget Candidate against Major Foodborne E. coli Serotypes and Methicillin-Resistant S. aureus.
    Sharaf M; Sewid AH; Hamouda HI; Elharrif MG; El-Demerdash AS; Alharthi A; Hashim N; Hamad AA; Selim S; Alkhalifah DHM; Hozzein WN; Abdalla M; Saber T
    Microbiol Spectr; 2022 Aug; 10(4):e0025022. PubMed ID: 35852338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New antimicrobial agents as therapy for resistant gram-positive cocci.
    Lentino JR; Narita M; Yu VL
    Eur J Clin Microbiol Infect Dis; 2008 Jan; 27(1):3-15. PubMed ID: 17899228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Surveillance on gram-positive bacteria isolated from patients with hospital acquired infections or community acquired infections].
    Li JT; Li Y; Wang J;
    Zhonghua Yi Xue Za Zhi; 2003 Mar; 83(5):365-74. PubMed ID: 12820911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methicillin- and Vancomycin-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococci Isolated from Hospital Foods: Prevalence and Antimicrobial Resistance Patterns.
    Afshari A; Taheri S; Hashemi M; Norouzy A; Nematy M; Mohamadi S
    Curr Microbiol; 2022 Sep; 79(11):326. PubMed ID: 36125553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A New Kind of Quinonic-Antibiotic Useful Against Multidrug-Resistant
    Campanini-Salinas J; Andrades-Lagos J; Gonzalez Rocha G; Choquesillo-Lazarte D; Bollo Dragnic S; Faúndez M; Alarcón P; Silva F; Vidal R; Salas-Huenuleo E; Kogan M; Mella J; Recabarren Gajardo G; Vásquez-Velásquez D
    Molecules; 2018 Jul; 23(7):. PubMed ID: 30029513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative in vitro activity of linezolid and five other antimicrobials against nosocomial isolates of methicillin-resistant Staphylococcus aureus, methicillin-resistant Staphylococcus epidermidis and vancomycin-resistant Enterococcus faecium.
    Metallidis S; Chatzidimitriou M; Nikolaidis P; Tsona A; Bisiklis A; Kollaras P; Tsiakiri E; Koumentaki E; Alexiou-Daniel S
    J Chemother; 2003 Oct; 15(5):442-8. PubMed ID: 14603881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.